Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradiscal BMC vs Corticosteroid for Discogenic LBP
NCT04735185Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Sep 2025
- Primary completion
- Nov 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Randomised, single-blind trial of autologous bone marrow derived mesenchymal stromal cells in chronic low back pain (CLBP) and degenerative disc disease (DDD) (2 arms), sponsored by Johns Hopkins University. Primary endpoint: Mean change in average low back pain score on 0-10 numerical rating scale at 3 months. Planned start Sep 2025; status: withdrawn.
02
Drugs
autologous bone marrow derived mesenchymal stromal cells
03
Conditions
chronic low back pain (CLBP)degenerative disc disease (DDD)
Beyond the preview
Go deeper on NCT04735185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04735185.